http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018512160-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2016-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2018512160-A |
| titleOfInvention | Methods for lung cancer typing |
| abstract | Methods and compositions for molecular subtyping of lung cancer samples are provided. Specifically, a method for assessing whether a patient's adenocarcinoma lung cancer subtype is terminal respiratory unit (TRU), proximal inflammatory (PI), or proximal proliferative (PP) is provided. Provided in the description. The method involves detecting the level of the classifier biomarkers of Tables 1-6 or a subset thereof in the lung cancer sample obtained from the patient at the nucleic acid level. Based in part on the level of the classifier biomarker, lung cancer samples are classified as TRU, PI, or PP samples. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7241353-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019516407-A |
| priorityDate | 2015-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 781.